NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

etoro logo Buy OTLK
*Your capital is at risk
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.
Predictor Target Session Target Price Result Direction Accuracy Score
Jul 23, 2025 $2.12 +1.92% $2.08 X 98.08% 0
Jul 23, 2025 $2.20 +5.77% $2.08 X 94.23% 0
Jul 22, 2025 $2.13 +3.25% $2.08 V 97.75% 1
Jul 22, 2025 $2.10 +2.03% $2.08 V 98.95% 2
Jul 22, 2025 $2.26 +3.67% $2.08 X 91.35% 1
Jul 21, 2025 $2.25 +3.08% $2.06 X 90.92% 0
Jul 21, 2025 $2.14 -1.92% $2.06 V 96.21% 1
Jul 21, 2025 $2.40 +10.09% $2.06 X 83.50% 0
Jul 18, 2025 $2.24 -2.82% $2.18 V 97.03% 1
Jul 18, 2025 $2.27 -1.76% $2.18 V 95.91% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE